- Combination of omalizumab and bee venom immunotherapy: does it work?
-
Yılmaz I, Bahçecioğlu SN, Türk M
- KMID: 2428869
- Asia Pac Allergy.
- 2018 Jan;8(1):e2.
- doi: 10.5415/apallergy.2018.8.e2
Bee venom immunotherapy (b-VIT) can be combined with omalizumab therapy in order to suppress systemic reactions developing due to b-VIT itself. Omalizumab acts as a premedication and gains time for... -
- CITED
-
- Close
- SHARE
-
- Close
- Is Omalizumab a Problem-Solving Remedy in Severe Asthma?
-
Kim DH, Jee YK
- KMID: 2402968
- Allergy Asthma Immunol Res.
- 2018 Mar;10(2):95-96.
- doi: 10.4168/aair.2018.10.2.95
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Omalizumab in recurring larynx angioedema: a case report
-
Ozturk AB, Kocaturk E
- KMID: 2397117
- Asia Pac Allergy.
- 2014 Apr;4(2):129-130.
- doi: 10.5415/apallergy.2014.4.2.129
Angioedema with swelling of larynx is a serious allergic reaction and can be life-threatening. It can occur after exposure to various triggers and usually it is very difficult for the... -
- CITED
-
- Close
- SHARE
-
- Close
- Omalizumab and unmet needs in severe asthma and allergic comorbidities in Japanese children
-
Nishima S, Kozawa M, Milligan K, Papadopoulos NG
- KMID: 2433668
- Asia Pac Allergy.
- 2019 Jan;9(1):e7.
- doi: 10.5415/apallergy.2019.9.e7
Childhood asthma is one condition within a family of allergic diseases, which includes allergic rhinitis, atopic dermatitis, and food allergy, among others. Omalizumab is an anti-IgE antibody therapy that was... -
- CITED
-
- Close
- SHARE
-
- Close
- Omalizumab as a Succesfull Therapy in Normocomplementemic Urticarial Vasculitis: A Series of Four Patients and Review of the Literature
-
Degirmentepe EN, Kızıltac K, Etikan P, Singer R, Memet B, Kocaturk E
- KMID: 2444868
- Ann Dermatol.
- 2019 Jun;31(3):335-338.
- doi: 10.5021/ad.2019.31.3.335
Urticarial vasculitis is an eruption characterized by inflamed itchy or painful red papules or plaques that resemble urticaria but last longer than 24 hours and heal with residual pigmentation or... -
- CITED
-
- Close
- SHARE
-
- Close
- Recalcitrant Atopic Dermatitis Treated with Omalizumab
-
Park SY, Choi MR, Na JI, Youn SW, Park KC, Huh CH
- KMID: 2265375
- Ann Dermatol.
- 2010 Aug;22(3):349-352.
- doi: 10.5021/ad.2010.22.3.349
Atopic dermatitis (AD) is a chronic cutaneous inflammatory disease. Various categories of therapeutic medications are used for treating AD. Omalizumab is a monoclonal anti-IgE antibody that binds to IgE molecules... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Omalizumab in a Patient with Angioedema Clinically Resembling a Hereditary Angioedema
-
Kutlu A, Karabacak , Aydın E, Akarsu S, Öztürk S
- KMID: 2164648
- Ann Dermatol.
- 2016 Jun;28(3):381-382.
- doi: 10.5021/ad.2016.28.3.381
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Successful management of severe cow's milk allergy with omalizumab treatment and CD-sens monitoring
-
Nilsson C, Nordvall L, Johansson , Nopp A
- KMID: 2397107
- Asia Pac Allergy.
- 2014 Oct;4(4):257-260.
- doi: 10.5415/apallergy.2014.4.4.257
Food allergy is common in children and young adults and may be difficult to diagnose and is at present treated with avoidance of the food in question. The aim of... -
- CITED
-
- Close
- SHARE
-
- Close
- A Long Term Case Series Study of the Effect of Omalizumab on Chronic Spontaneous Urticaria
-
Lefevre AC, Deleuran M, Vestergaard C
- KMID: 2171798
- Ann Dermatol.
- 2013 May;25(2):242-245.
- doi: 10.5021/ad.2013.25.2.242
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Therapeutic Effect of Omalizumab in Severe Asthma: A Real-World Study in Korea
-
Lee JH, Lee HY, Jung CG, Ban GY, Shin YS, Ye YM, Nahm DH, Park HS
- KMID: 2402971
- Allergy Asthma Immunol Res.
- 2018 Mar;10(2):121-130.
- doi: 10.4168/aair.2018.10.2.121
PURPOSE: Omalizumab, an anti-immunoglobulin E (IgE) monoclonal antibody, has proved to be effective for the treatment of severe asthma. However, there is no direct evidence of effectiveness of omalizumab in... -
- CITED
-
- Close
- SHARE
-
- Close
- Updated treatment guideline of chronic spontaneous urticaria
-
Roh JY
- KMID: 2431993
- J Korean Med Assoc.
- 2019 Jan;62(1):37-46.
- doi: 10.5124/jkma.2019.62.1.37
Chronic spontaneous urticaria (CSU), also known as chronic idiopathic urticaria, is a common chronic inflammatory skin disorder that has a prevalence of 0.5% to 1% in the general population. It... -
- CITED
-
- Close
- SHARE
-
- Close
- Real-life Efficacy of Omalizumab After 9 Years of Follow-up
-
Menzella F, Galeone C, Formisano , Castagnetti C, Ruggiero P, Simonazzi , Zucchi L
- KMID: 2378200
- Allergy Asthma Immunol Res.
- 2017 Jul;9(4):368-372.
- doi: 10.4168/aair.2017.9.4.368
Omalizumab is frequently used as add-on treatment to inhaled corticosteroids (ICS) and long-acting β2-agonists in patients with suboptimal control of severe asthma. Patients with severe asthma will typically require chronic... -
- CITED
-
- Close
- SHARE
-
- Close
- Successful prevention of recurrent anaphylactic events with anti-immunoglobulin E therapy
-
Lee J
- KMID: 2397116
- Asia Pac Allergy.
- 2014 Apr;4(2):126-128.
- doi: 10.5415/apallergy.2014.4.2.126
Anaphylaxis is a fatal and systemic allergic reaction, which can be prevented by avoiding exposure to a causative agent. However, the causative agent cannot be identified in all cases and... -
- CITED
-
- Close
- SHARE
-
- Close
- Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations
-
Kaplan AP
- KMID: 2421657
- Allergy Asthma Immunol Res.
- 2017 Nov;9(6):477-482.
- doi: 10.4168/aair.2017.9.6.477
The treatment of chronic spontaneous urticaria begins with antihistamines; however, the dose required typically exceeds that recommended for allergic rhinitis. Second-generation, relatively non-sedating H1-receptor blockers are typically employed up to... -
- CITED
-
- Close
- SHARE
-
- Close
- Successful Remission of Recurrent Anaphylaxis after Omalizumab Administration in a Patient with Systemic Mastocytosis
-
Moon H, Jang HJ, Lee CG, Kim YC, Yoo SH, Lee DS, Kang HR
- KMID: 2435039
- Korean J Med.
- 2018 Feb;93(1):68-73.
- doi: 10.3904/kjm.2018.93.1.68
Mastocytosis is a disorder characterized by abnormal mast cell proliferation and accumulation in one or more tissues. It presents in two major variants: cutaneous mastocytosis and systemic mastocytosis. Because the... -
- CITED
-
- Close
- SHARE
-
- Close
- Omalizumab Improves Quality of Life and Asthma Control in Chinese Patients With Moderate to Severe Asthma: A Randomized Phase III Study
-
Li J, Kang J, Wang C, Yang J, Wang L, Kottakis I, Humphries , Zhong N, China Omalizumab Study Group
- KMID: 2165915
- Allergy Asthma Immunol Res.
- 2016 Jul;8(4):319-328.
- doi: 10.4168/aair.2016.8.4.319
PURPOSE: Omalizumab is the preferred add-on therapy for patients with moderate-to-severe persistent allergic asthma and has demonstrated efficacy and safety in various ethnicities. This study evaluated the efficacy and safety... -
- CITED
-
- Close
- SHARE
-
- Close
- Oral Immunotherapy for Food Allergy: Towards a New Horizon
-
Khoriaty E, Umetsu DT
- KMID: 2167001
- Allergy Asthma Immunol Res.
- 2013 Jan;5(1):3-15.
- doi: 10.4168/aair.2013.5.1.3
Food allergy has increased dramatically in prevalence over the past decade in westernized countries, and is now a major public health problem. Unfortunately for patients with food allergy, there is... -
- CITED
-
- Close
- SHARE
-
- Close
- Favorable outcome of omalizumab treatment in a patient with idiopathic anaphylaxis
-
Ban GY, Yang EM, Kim JH, Shin YS, Ye YM, Nahm DH, Park HS
- KMID: 2218651
- Allergy Asthma Respir Dis.
- 2015 Sep;3(5):380-383.
- doi: 10.4168/aard.2015.3.5.380
Anaphylaxis is a severe and life-threatening systemic reaction. Despite the extensive evaluation to determine the cause, 30%-60% of cases of anaphylaxis in adults remain idiopathic. Recently, omalizumab treatment has been... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Omalizumab Treatment in Patients With Refractory Chronic Urticaria
-
Nam YH, Kim JH, Jin HJ, Hwang EK, Shin YS, Ye YM, Park HS
- KMID: 2167026
- Allergy Asthma Immunol Res.
- 2012 Nov;4(6):357-361.
- doi: 10.4168/aair.2012.4.6.357
PURPOSE: Chronic urticaria (CU) is a common and debilitating disease, and the need for effective treatment has increased. Omalizumab may be an alternative regimen in patients with CU who do... -
- CITED
-
- Close
- SHARE
-
- Close
- Personalized Medicine in Allergy
-
Ferrando M, Bagnasco D, Varricchi , Bernardi S, Bragantini A, Passalacqua G, Canonica G
- KMID: 2355890
- Allergy Asthma Immunol Res.
- 2017 Jan;9(1):15-24.
- doi: 10.4168/aair.2017.9.1.15
Allergic disease is among the most common pathologies worldwide and its prevalence has constantly increased up to the present days, even if according to the most recent data it seems... -
- CITED
-
- Close
- SHARE
-
- Close
